AI-generated summary
The authors reviewed randomized clinical trials of photobiomodulation in incomplete spinal cord or peripheral nerve injuries, identifying nineteen studies, most on carpal tunnel syndrome. They report an inclination toward improvement in strength, sensitivity and pain, though device settings varied widely and data could not be easily combined.
- Studies included
- 19
- Who or what was studied
- Patients with incomplete spinal cord injuries or peripheral nerve injuries, mainly carpal tunnel syndrome
- Wavelengths
- 620, 1400 nm
- Limits stated in the abstract
- The abstract notes small samples, short follow-up, great heterogeneity in device configuration and irradiation parameters, and difficulty with data synthesis.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 620 nm, 1400 nm
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Systematic review, Photobiomodulation therapy, Heterogeneity, Fibromyalgia. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.